Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DETACT
2022-003303-14Phase 4Active
- Sponsor
- Medical University of Vienna
- Start
- Dec 2022
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dupilumab in severe asthma, sponsored by Medical University of Vienna. Started Dec 2022; status: active.
02
Drugs
03
Conditions
severe asthma
Beyond the preview
Go deeper on 2022-003303-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003303-14.